Success Story: Safeguarding Crops and Clinics: An EB-2 NIW Victory for a Vietnamese Biotechnology Postdoc
Client’s Testimonial:
"Thank you and your team for your support and assistance throughout the preparation and processing of my I-140 package. I truly appreciate your help."
On March 31st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Vietnam
State of Residence at the Time of Filing: California
Approval Notice Date: March 31st, 2026
Processing Time: 2 months, 16 days (Premium Processing Requested)
Case Summary:
On March 31st, 2026, North America Immigration Law Group (Chen Immigration Law Associates) successfully secured an EB-2 National Interest Waiver (NIW) for a Postdoctoral Scholar in the field of biotechnology. The client, originally from Vietnam, had his petition approved in just 2 months and 16 days.
By strictly focusing on objective metrics and urgent national priorities, our legal team built an undeniable case for this exceptional researcher without relying on the prestige of specific institutional names.
Combating a $200 Billion Agricultural Crisis and Antimicrobial Resistance
Holding a Ph.D. in biotechnology, the client focuses his proposed endeavor on exploring microbe-bacteriophage interactions to develop precision phage therapies and robust discovery pipelines. We successfully argued that this research targets two distinct but equally critical national vulnerabilities:
- Agricultural Resilience: In the United States, fungal pathogens cause up to 20% of annual crop losses, translating to approximately $200 billion in damage. By studying the behavior of devastating agricultural strains, the client is developing sustainable phage-based biocontrol strategies that protect the domestic food supply while reducing harmful reliance on chemical pesticides.
- Public Health Bio-defense: The client's research also combats multidrug-resistant human pathogens, addressing a major public health emergency. By designing therapies against common healthcare-associated, antimicrobial-resistant pathogens, his work directly advances the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria.
A Proven Record of Elite Scientific Influence
Our team documented his prolific output of 10 peer-reviewed journal articles (3 of which are first-authored) and 1 first-authored conference abstract. We emphasized the extreme prestige of his publication venues, noting that his work consistently appears in highly ranked, world-renowned scientific journals. His published body of work has amassed 103 independent citations.
Expert Validation and a Decisive Victory
We corroborated his scientific influence with expert testimony from leading authorities at a premier U.S. research university and a prestigious national laboratory. These independent experts affirmed that his precision phage therapy innovations position the United States as a global leader in agricultural biotechnology and microbial control.
By meticulously aligning his dual-purpose biological research with federal technological priorities, we ensured a swift and definitive NIW approval. We proudly congratulate our client on this milestone and look forward to his continued contributions to U.S. health and agricultural security.